TRAF-interacting Protein (TRIP): A Novel Component of the Tumor Necrosis Factor Receptor (TNFR)- and CD30-TRAF Signaling Complexes That Inhibits TRAF2-mediated NF-κB Activation

Documenti analoghi

• TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors
  di: Jennifer Wagner, et al.
  Pubblicazione: (2025-01-01)
• Stimulus-dependent Synergism of the Antiapoptotic Tumor Necrosis Factor Receptor–associated Factor 2 (TRAF2) and Nuclear Factor κB Pathways
  di: Lee, Soo Young, et al.
  Pubblicazione: (1998)
• TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-κB pathway by TRAF-binding TNFRs
  di: Hauer, Julia, et al.
  Pubblicazione: (2005)
• TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation
  di: Thakar, Nilay Y., et al.
  Pubblicazione: (2015)
• Tumor Necrosis Factor (TNF) Receptor-associated Factor (TRAF)-interacting Protein (TRIP) Negatively Regulates the TRAF2 Ubiquitin-dependent Pathway by Suppressing the TRAF2-Sphingosine 1-Phosphate (S1P) Interaction
  di: Park, Eui-Soon, et al.
  Pubblicazione: (2015)